Home・Akciju saraksts・AngioDynamics Inc

AngioDynamics Inc

Slēgts

SektorsVeselības aprūpe

15.75 0.7

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

15.59

Max

15.71

Galvenie mērījumi
By Trading Economics
Ienākumi	-3.3M -11M
Pārdošana	8.2M 87M
EPS	-0.07
Peļņas marža	-13.169
Darbinieki	632
EBITDA	-26M -28M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+33.84% upside

Dividendes
By Acuity
Nākamie ieņēmumi	2026. g. 1. okt.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	99M 627M
Iepriekšējā atvēršanas cena	15.05
Iepriekšējā slēgšanas cena	15.75

Ziņu noskaņojums

By Acuity

50%

116 / 340 Rangs Healthcare

AngioDynamics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 7. aug. 19:33 UTC

News

AngioDynamics shares are rising despite a downgrade to Q3 2028 earnings estimates. Analysts from Canaccord Genuity and HC Wainwright raised their price targets.

2026. g. 6. aug. 19:56 UTC

AngioDynamics shares are lower during Thursday's session, with no specific news identified. The stock remains above its 20-day moving average.

2026. g. 5. aug. 19:46 UTC

AngioDynamics Inc shares are lower amid broader market caution following ADP's report of only 44,000 private sector jobs added in July.

2026. g. 4. aug. 19:31 UTC

AngioDynamics Inc shares are lower today, driven by significant declines in the Health Care Equipment sub-sector. No specific company news was identified.

2026. g. 3. aug. 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

2026. g. 31. jūl. 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

2026. g. 30. jūl. 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

2026. g. 29. jūl. 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

2026. g. 28. jūl. 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

2026. g. 27. jūl. 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

2026. g. 24. jūl. 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

2026. g. 23. jūl. 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

2026. g. 22. jūl. 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

2026. g. 21. jūl. 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

2026. g. 20. jūl. 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Salīdzinājums

Cenas izmaiņa

AngioDynamics Inc Prognoze

Cenas mērķis

By TipRanks

33.84% augšup

Prognoze 12 mēnešiem

Vidējais 21 USD 33.84%

Augstākais 24 USD

Zemākais 19 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi AngioDynamics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam AngioDynamics Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

116 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.